Cancer immunotherapy is a type of cancer treatment that harnesses the immune system to fight cancer cells. The treatment ...

In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ ...

Researchers sought to determine whether zanubrutinib combined with rituximab and lenalidomide would improve remission rates in older adults with newly diagnosed DLBCL.

Magnetic nanoparticles engineered T cells inside living mice and guided them into solid tumors, achieving over 90% tumor ...

Trojan horse” approach may enable ‘antigen-independent’ therapy with potential to treat cancers not traditionally amenable to immunotherapy.

Study suggests CD4+ T cells mediate these immune-related toxicities ...

New research suggests that a breast cancer vaccine developed decades ago may have triggered a lasting immune memory response that can now be significantly boosted by a newly developed antibody.

Marginal zone lymphoma treatment evolves with promising CAR T-cell therapies, addressing unmet needs in aggressive cases and improving patient outcomes.

How do immune cells strike a balance, unleashing rapid attacks against pathogens or cancer, while avoiding damage to healthy ...

Immunotherapeutic interventions are showing promise in cancer treatment, but challenges like low response rates, off-target delivery, and toxicity still persist. Immunomodulatory nanocomplexes (ImNcs) ...